igf-1 lr3 vial - 1mg IGF-1 LR3 (1 mg) –
Description
S., Thompson, R
For targets with no existing fluorophore conjugated antibody the following primary antibodies were used: anti NRF2 polyclonal (1:200, Thermofisher, PA5-27882)
Following sequence verification the construct was transformed into BL21(DE3) Escherichia coli for expression
The liver is the ideal system in which to study wound healing
We provide superbills for out-of-network reimbursement
Vesicles (2018)
